BD-1047
跳至導覽
跳至搜尋
| File:BD-1047 Structure.svg | |
| 臨床資料 | |
|---|---|
| ATC碼 |
|
| 識別資訊 | |
| |
| CAS號 | 138356-20-4 ☒ |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| E編碼 | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Module:EditAtWikidata第29行Lua錯誤:attempt to index field 'wikibase' (a nil value) |
| 化學資訊 | |
| 化學式 | C13H20Cl2N2 |
| 摩爾質量 | 275.22 g·mol−1 |
| 3D模型(JSmol) | |
| |
BD-1047是一種含氮有機氯化合物,化學式C
13H
20Cl
2N
2,能作為σ受體特別是σ1的選擇性拮抗劑,可用於緩解神經性疼痛[1][2]。
參考文獻[編輯]
- ↑ Skuza G, Rogóz Z. Effect of BD 1047, a sigma1 receptor antagonist, in the animal models predictive of antipsychotic activity. Pharmacological Reports. 2006, 58 (5): 626–35. PMID 17085854.
- ↑ Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Kim KW, Han HJ, Beitz AJ, Na HS, Lee JH. Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain. Anesthesiology. November 2008, 109 (5): 879–89. PMID 18946301. doi:10.1097/ALN.0b013e3181895a83 可免費查閱.